Anonymous
Guest
Anonymous
Guest
There seems to no accountability and little impact to upper management. The SP&O organization announced a 36% reduction in force yesterday, yet not a single VP position was impacted. In fact, they actually filled an existing vacancy amongst the VP ranks. So 36% less manpower, but we still need all the VPs?
Yet another testament to GSK's manangement.